abrdn rolls out new passive hedge fund index institutional investment platform
Leading global asset manager abrdn has announced the launch of the abrdn Eclipse fund platform, which the firm describes as “an industry-first offering for institutional investors” that provides passive exposure to hedge fund strategies underpinned by indices from hedge fund index provider Hedge Fund Research (HFR).
Eclipse offers abrdn’s global clients access to the flagship investable hedge fund benchmark HFRI 500 index – as well as eight sub-strategy indices comprising long/short equity, equity market-neutral, merger arbitrage, event driven multi-strategy, discretionary macro, systematic macro, fixed income relative value, and volatility relative value strategies.
The firm said the launch, which comes after several years of collaboration with HFR, is the latest innovation from the abrdn alternatives team, which includes more than 40 people focused on alternatives research, index and structuring, risk, execution, portfolio construction and operational due diligence. The team oversees some USD14 billion of assets on behalf of clients globally and across a range of active and passive solutions.
“In an unsettled market environment, investors are looking for unique, differentiated sources of returns leading them towards alternatives – and hedge funds, in particular, were making a strong case for an increased allocation even before the current market dislocation took hold,” says Darren Wolf, global head of investments, alternatives at abrdn.
“Working with our partners at HFR and drawing upon abrdn’s expertise in delivering investment solutions, we have arrived at a first-of-its-kind proposition that is highly accessible, flexible in its delivery to clients and built to last. We are delighted to officially launch this platform and continue to help it grow as investors are reminded of the value proposition that this exposure can provide alongside a portfolio of traditional assets.”
Says Joseph Nichols, founder at HFR: “abrdn’s launch of tracking products for HFR’s benchmarks provides allocators with new options and solutions, including a way to address unfunded exposure risk, reduce active selection risk and a passive, cost-effective, low-risk avenue to achieving market performance. “